Angeles Investment Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,300
Closed -$355K 202
2024
Q3
$355K Sell
5,300
-640
-11% -$52.6K 0.02% 144
2024
Q2
$673K Buy
5,940
+93
+2% +$11.8K 0.03% 66
2024
Q1
$811K Sell
5,847
-2,106
-26% -$265K 0.04% 58
2023
Q4
$987K Buy
7,953
+929
+13% +$94.9K 0.06% 41
2023
Q3
$655K Buy
+7,024
New +$792K 0.05% 53

Other funds holding DXCM

Angeles Investment Advisors's DXCM Position: Q4 2024 in Review

Angeles Investment Advisors sold out of DexCom (DXCM) in Q4 2024, closing a stake of 5,300 shares — an estimated $355K sold.

Angeles Investment Advisors first reported a position in DXCM in Q3 2023 and held it in 5 quarters. The position peaked at $987K in Q4 2023. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Angeles Investment Advisors reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Angeles Investment Advisors sold 5,300 DexCom shares in Q4 2024, an estimated $355K.
  • Angeles Investment Advisors first reported a position in DexCom in Q3 2023 and held it in 5 quarters.
  • Angeles Investment Advisors's DexCom position peaked at $987K in Q4 2023.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Angeles Investment Advisors's 13F filing for Q4 2024, filed 11 Feb 2025.